EUROPEAN MARKETS FOR ECG AND CARDIOVASCULAR DISEASE-RELATED IN VITRO DIAGNOSTIC NEAR-PATIENT TESTING PRODUCTS

277 Pages | 94 Exhibits | 2009 Analysis | Forecasts Through 2013 Product Family: Market Reports




OVERVIEW:
In Europe, more than 4.3 million people die every year from cardiovascular diseases/disorders such as stroke and coronary heart disease (which by itself is the most common cause of death in the region). Cardiovascular conditions result in direct and indirect costs that exceed €192 billion annually in the countries that comprise the European Union.

In 2008, the combined European market for electrocardiography products and cardiovascular disease-related in vitro diagnostic near-patient testing products was valued at approximately $556.4 million. Among France, Germany, Italy, Spain, and the U.K., the largest country market was Germany, with sales of approximately $213.7 million (38.4% of the total market value). The German market was followed by France with $191.0 million in sales (34.3%), the U.K. with $68.7 million (12.4%), Italy with $47.4 million (8.5%), and Spain with $35.6 million (6.4%)

This dynamic, new report from Medtech Insight includes analyses of products, markets, competitors, and opportunities in the fields of electrocardiography and in vitro diagnostic near-patient testing.

Covered topics in this report include cardiovascular disease-related in vitro diagnostic near-patient testing products available in Europe-including those for the assessment of cardiac markers, cholesterol/lipid levels, and coagulation status-along with test volumes, sales volumes, and competitive analyses; cardiovascular disease/disorder statistics for Europe; discussions of the healthcare markets of France, Germany, Italy, Spain, and the U.K.; and electrocardiography products, procedure volumes, sales volumes, and competitor comparisons.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Electrocardiography Products Market
ii. Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient  Testing Products Market
	a. In Vitro Diagnostic Near-Patient Cardiac Markers Testing Products Segment
	b. In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products Segment
	c. In Vitro Diagnostic Near-Patient Coagulation Testing Products Segment
iii. Methodology

Exhibit ES-1: Europe, Electrocardiography and Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products, Combined Market Forecast, 2008-2013
Exhibit ES-2: Europe, Electrocardiography and Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products, Market Forecast, by Country, 2008-2013
Exhibit ES-3: Europe, Electrocardiography Products, Combined Market Forecast, 2008-2013
Exhibit ES-4: Europe, Electrocardiography Products, Market Forecast, by Country, 2008-2013
Exhibit ES-5: Europe, Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products, Combined Market Forecast, 2008-2013
Exhibit ES-6: Europe, Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products, Market Forecast, by Country, 2008-2013
Exhibit ES-7: Europe, In Vitro Diagnostic Near-Patient Cardiac Marker  Testing Products, Combined Market Forecast, 2008-2013
Exhibit ES-8: Europe, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products, Market Forecast, by Country, 2008-2013
Exhibit ES-9: Europe, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Combined Market Forecast, 2008-2013
Exhibit ES-10: Europe, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Market Forecast, by Country, 2008-2013
Exhibit ES-11: Europe, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Combined Market Forecast, 2008-2013
Exhibit ES-12: Europe, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Market Forecast, by Country, 2008-2013

1. EUROPEAN HEALTHCARE MARKETS

1.1 The European Union
	1.1.1 A Common Currency
	1.1.2 Regulatory Policies
	1.1.3 Reimbursement
	1.1.4 Healthcare Spending
1.2 Selected European National Healthcare Profiles
	1.2.1 France
		1.2.1.1 Healthcare Organization and Reform
		1.2.1.2 Hospital Services
		1.2.1.3 Medical Device Reimbursement
	1.2.2 Germany
		1.2.2.1 Healthcare Organization and Reform
		1.2.2.2 Hospital Services
		1.2.2.3 Medical Device Reimbursement
	1.2.3 Italy
		1.2.3.1 Healthcare Organization and Reform
		1.2.3.2 Hospital Services
		1.2.3.3 Medical Device Reimbursement
	1.2.4 Spain
		1.2.4.1 Healthcare Organization and Reform
		1.2.4.2 Hospital Services
		1.2.4.3 Medical Device Reimbursement
	1.2.5 United Kingdom
		1.2.5.1 Healthcare Organization and Reform
		1.2.5.2 Hospital Services
		1.2.5.3 Medical Device Reimbursement

Exhibit 1-1: European Union, Medical Devices Risk Classification System
Exhibit 1-2: European Union Population Statistics Comparison for the Years 1998, 2008, and 2018
Exhibit 1-3: France, Selected National Healthcare Statistics
Exhibit 1-4: Germany, Selected National Healthcare Statistics
Exhibit 1-5: Italy, Selected National Healthcare Statistics
Exhibit 1-6: Spain, Selected National Healthcare Statistics
Exhibit 1-7: United Kingdom, Selected National Healthcare Statistics

2. OVERVIEW OF SELECTED CARDIOVASCULAR DISEASES/DISORDERS

2.1 The Heart and Circulatory System
	2.1.1 The Cardiac Conduction System
	2.1.2 The Heart Valves
2.2 Diseases/Disorders Involving the Vasculature
	2.2.1 Coronary Heart Disease
		2.2.1.1 Atherosclerosis
			2.2.1.1.1 Description
			2.2.1.1.2 Statistics
		2.2.1.2 Angina Pectoris
			2.2.1.2.1 Description
			2.2.1.2.2 Statistics
		2.2.1.3 Myocardial Infarction
			2.2.1.3.1 Description
			2.2.1.3.2 Statistics
	2.2.2 Hypertension
		2.2.2.1 Description
			2.2.2.1.1 Systolic and Diastolic Pressures
			2.2.2.1.2 Prehypertension
		2.2.2.2 Statistics
	2.2.3 Aneurysm
		2.2.3.1 Description
		2.2.3.2 Statistics
	2.2.4 Stroke
		2.2.4.1 Description
		2.2.4.2 Statistics
2.3 Diseases/Disorders Involving the Cardiac Conduction System
	2.3.1 Types
		2.3.1.1 Bradycardia
			2.3.1.1.1 Description
		2.3.1.2 Sick Sinus Syndrome
			2.3.1.2.1 Description
		2.3.1.3 Heart Block
			2.3.1.3.1 Description
		2.3.1.4 Atrial Fibrillation
			2.3.1.4.1 Description
		2.3.1.5 Tachycardia
			2.3.1.5.1 Description
		2.3.1.6 Ventricular Fibrillation
			2.3.1.6.1 Description
	2.3.2 Statistics
2.4 Diseases/Disorders Involving the Myocardium
	2.4.1 Heart Defects
		2.4.1.1 Description
		2.4.1.2 Statistics
	2.4.2 Heart Failure
		2.4.2.1 Description
		2.2.4.2 Statistics
	2.4.3 Rheumatic Fever/Rheumatic Heart Disease
		2.4.3.1 Description
		2.4.3.2 Statistics
	2.4.4 Heart Valve Disorders
		2.4.4.1 Types
			2.4.4.1.1 Valvular Stenosis
				2.4.4.1.1.1 Description
			2.4.4.1.2 Valvular Regurgitation
				2.4.4.1.2.1 Description
			2.4.4.1.3 Valve Prolapse
				2.4.4.1.3.1 Description
		2.4.4.2 Statistics

Exhibit 2-1: Cross-Section Diagram of the Heart
Exhibit 2-2: Cross-Section Diagram of the Heart Valves
Exhibit 2-3: Men, Number of Deaths due to Cardiovascular Disease, Selected European Countries
Exhibit 2-4: Women, Number of Deaths due to Cardiovascular Disease, Selected European Countries
Exhibit 2-5: Total Cholesterol Levels in Men, Selected European Countries, 2005 and 2010
Exhibit 2-6: Total Cholesterol Levels in Women, Selected European Countries, 2005 and 2010
Exhibit 2-7: Europe, Atherosclerosis Prevalence, by Country
Exhibit 2-8: Standard Angina Pectoris Classification
Exhibit 2-9: Europe, Coronary Events Incidence Rates, Selected MONICA Project Populations, by Gender Group
Exhibit 2-10: Europe, Myocardial Infarction Prevalence, by Country
Exhibit 2-11: Europe, Systolic Blood Pressure Levels, Selected MONICA Project Populations, by Gender Group
Exhibit 2-12: Mean Systolic Blood Pressure Levels in Men, Selected European Countries, 2005 and 2010
Exhibit 2-13: Mean Systolic Blood Pressure Levels in Women, Selected European Countries 2005 and 2010
Exhibit 2-14: Europe, Hypertension Prevalence, by Country
Exhibit 2-15: Europe, Aneurysm Prevalence, by Country
Exhibit 2-16: Europe, Stroke Disability and Mortality, By Selected Country
Exhibit 2-17: Europe, Stroke Prevalence, by Country
Exhibit 2-18: Europe, Cardiac Dysrhythmia Prevalence, by Country
Exhibit 2-19: Congenital Heart Defects, Estimated Number of Simple and Complex Cases in the United Kingdom, 2000 and 2010
Exhibit 2-20: United Kingdom, Heart Failure Prevalence, Selected Study Data
Exhibit 2-21: Europe, Heart Failure Prevalence, by Country
Exhibit 2-22: Rheumatic Heart Disease, Estimated Number of Reported Cases, Selected Countries/Regions
Exhibit 2-23: Rheumatic Heart Disease Mortality, Selected European Countries
Exhibit 2-24: Euro Heart Survey on Valvular Heart Disease Patient Population, Native Heart Valve Disorders, by Type
Exhibit 2-25: Europe, Heart Valve Disorder Prevalence, by Country

3. ELECTOCARDIOGRAPHY PRODUCTS

3.1 Types of Electrocardiography Procedures
	3.1.1 Resting Electrocardiography
	3.1.2 Exercise/Stress Electrocardiography
	3.1.3 Holter Monitoring
	3.1.4 Event Monitoring
3.2 Electrocardiography, Procedure Volumes
3.3 Electrocardiography Systems, Market Analysis
	3.3.1 Products
	3.3.2 Market Forecast
	3.3.3 Competitors

Exhibit 3-1: Normal Electrocardiogram Trace
Exhibit 3-2: Europe, Electrocardiography, Combined Procedure Volumes Forecast, 2008-2013
Exhibit 3-3: Europe, Electrocardiography, Procedure Volumes Forecast, by Country, 2008-2013
Exhibit 3-4: 2009, Selected Electrocardiography Systems
Exhibit 3-5: Europe, Electrocardiography Products, Combined Market Forecast, 2008-2013
Exhibit 3-6: Europe, Electrocardiography Products, Market Forecast, by Country, 2008-2013
Exhibit 3-7: France, Electrocardiography Products, Market Forecast, 2008-2013
Exhibit 3-8: Germany, Electrocardiography Products, Market Forecast, 2008-2013
Exhibit 3-9: Italy, Electrocardiography Products, Market Forecast, 2008-2013
Exhibit 3-10: Spain, Electrocardiography Products, Market Forecast, 2008-2013
Exhibit 3-11: United Kingdom, Electrocardiography Products, Market Forecast, 2008-2013
Exhibit 3-12: 2008, Europe, Electrocardiography Products Market, Share by Supplier

4. CARDIOVASCULAR DISEASE-RELATED IN VITRO DIAGNOSTIC NEAR-PATIENT TESTING PRODUCTS

4.1 In Vitro Diagnostic Near-Patient Testing for Cardiac Markers
	4.1.1 Types of Tests
		4.1.1.1 Creatine Kinase-MB
		4.1.1.2 Myoglobin
		4.1.1.3 Troponin-I and Troponin-T
		4.1.1.4 Natriuretic Peptides
	4.1.2 In Vitro Diagnostic Near-Patient Cardiac Marker Assessment, Test Volumes Forecast
	4.1.3 In Vitro Diagnostic Near-Patient Cardiac Marker Testing Devices, Market Analysis
		4.1.3.1 Products
		4.1.3.2 Market Forecast
		4.1.3.3 Competitors
4.2 In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing
	4.2.1 Types of Tests
		4.2.1.1 Total Cholesterol
		4.2.1.2 Low-Density Lipoprotein
		4.2.1.3 High-Density Lipoprotein
		4.2.1.4 Triglycerides
	4.2.2 In Vitro Diagnostic Near-Patient Cholesterol/Lipid Assessment, Test Volumes Forecast
	4.2.3 In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Devices, Market Analysis
		4.2.3.1 Products
		4.2.3.2 Market Forecast
		4.2.3.3 Competitors
4.3 In Vitro Diagnostic Near-Patient Coagulation Testing
	4.3.1 Types of Tests
		4.3.1.1 Activated Clotting Time
		4.3.1.2 Activated Partial Thromboplastin Time
		4.3.1.3 Bleeding Time
		4.3.1.4 Prothrombin Time
		4.3.1.5 Thrombin Clotting Time
		4.3.1.6 Platelet Count/Function Determination
	4.3.2 In Vitro Diagnostic Near-Patient Coagulation Assessment, Test Volumes Forecast
	4.3.3 In Vitro Diagnostic Near-Patient Coagulation Testing Devices, Market Analysis
		4.3.3.1 Products
		4.3.3.2 Market Forecast
		4.3.3.3 Competitors
4.4 Combined Market for Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products

Exhibit 4-1: In Vitro Diagnostic Cardiac Marker Testing, Selected Applications
Exhibit 4-2: Medical Conditions Associated with Elevated Natriuretic Peptide Levels
Exhibit 4-3: Selected Investigated Clinical Applications or Heart Failure-Related Natriuretic Peptide Testing
Exhibit 4-4: Europe, In Vitro Diagnostic Near-Patient Cardiac Marker Assessment, Combined Test Volumes Forecast, 2008-2013
Exhibit 4-5: Europe, In Vitro Diagnostic Near-Patient Cardiac Marker Test Volumes, by Country, 2008-2013
Exhibit 4-6: 2009, Selected In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products
Exhibit 4-7: Europe, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products, Combined Market Forecast, 2008-2013
Exhibit 4-8: Europe, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products, Market Forecast, by Country, 2008-2013
Exhibit 4-9: France, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products, Market Forecast, 2008-2013
Exhibit 4-10: Germany, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products, Market Forecast, 2008-2013
Exhibit 4-11: Italy, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products, Market Forecast, 2008-2013
Exhibit 4-12: Spain, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products, Market Forecast, 2008-2013
Exhibit 4-13: United Kingdom, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products, Market Forecast, 2008-2013
Exhibit 4-14: 2008, Europe, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products Market, Share by Supplier
Exhibit 4-15: Europe, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Assessment, Combined Test Volumes Forecast, 2008-2013
Exhibit 4-16: Europe, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Test Volumes, by Country, 2008-2013
Exhibit 4-17: 2009, Selected In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products
Exhibit 4-18: Europe, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Combined Market Forecast, 2008-2013
Exhibit 4-19: Europe, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Market Forecast, by Country, 2008-2013
Exhibit 4-20: France, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Market Forecast, 2008-2013
Exhibit 4-21: Germany, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Market Forecast, 2008-2013
Exhibit 4-22: Italy, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Market Forecast, 2008-2013
Exhibit 4-23: Spain, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Market Forecast, 2008-2013
Exhibit 4-24: United Kingdom, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Market Forecast, 2008-2013
Exhibit 4-25: 2008, Europe, In Vitro Diagnostic Near-Patient Cholesterol/ Lipid Testing Products Market, Share by Supplier
Exhibit 4-26: Europe, In Vitro Diagnostic Near-Patient Coagulation Assessment, Combined Test Volumes Forecast, 2008-2013 4-54
Exhibit 4-27: Europe, In Vitro Diagnostic Near-Patient Coagulation Test Volumes, by Country, 2008-2013
Exhibit 4-28: 2009, Selected In Vitro Diagnostic Near-Patient Coagulation Testing Products
Exhibit 4-29: Europe, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Combined Market Forecast, 2008-2013
Exhibit 4-30: Europe, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Market Forecast, by Country, 2008-2013
Exhibit 4-31: France, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Market Forecast, 2008-2013
Exhibit 4-32: Germany, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Market Forecast, 2008-2013
Exhibit 4-33: Italy, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Market Forecast, 2008-2013
Exhibit 4-34: Spain, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Market Forecast, 2008-2013
Exhibit 4-35: United Kingdom, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Market Forecast, 2008-2013
Exhibit 4-36: 2008, Europe, In Vitro Diagnostic Near-Patient Coagulation Testing Products Market, Share by Supplier
Exhibit 4-37: Europe, Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products, Combined Market Forecast, 2008-2013
Exhibit 4-38: Europe, Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products, Market Forecast, by Country, 2008-2013

5. COMPANY PROFILES

5.1 Abbott Laboratories
5.2 Accumetrics, Inc.
5.3 Cardiac Science Corporation
5.4 GE Healthcare, Inc./General Electric Company
5.5 International Technidyne Corporation/Thoratec Corporation
5.6 Inverness Medical Innovations, Inc.
5.7 Medtronic, Inc.
5.8 Nanogen, Inc.
5.9 Philips Healthcare/Royal Philips Electronics NV
5.10 Roche Diagnostics/F. Hoffmann La-Roche LTD/Roche Group
5.11 Siemens Healthcare Diagnostics/Siemens AG
5.12 Welch Allyn

APPENDIX COMPANY LISTING


COMPANIES COVERED:

  1. Abbott Laboratories
  2. Accumetrics, Inc.
  3. Cardiac Science Corporation
  4. GE Healthcare, Inc./General Electric Company
  5. International Technidyne Corporation/Thoratec Corporation
  6. Inverness Medical Innovations, Inc.
  7. Medtronic, Inc.
  8. Nanogen, Inc.
  9. Philips Healthcare/Royal Philips Electronics NV
  10. Roche Diagnostics/F. Hoffmann La-Roche LTD/Roche Group
  11. Siemens Healthcare Diagnostics/Siemens AG
  12. Welch Allyn
Contact Us

Need help finding medtech research? Let us help you!